Botox Whistleblower Case Settles for $600 Million
Pharmaceutical manufacturer Allergan, Inc. has agreed to pay $225 million to resolve civil allegations that it unlawfully promoted its drug Botox® Therapeutic for unapproved uses…
Read More »Pharma 101 – Pharmaceutical Fraud
Pharmaceutical Fraud News & Insight form the Qui Tam and False Claims Act Perspective
Contact FormTag Archives: False Claims Act
Consequences of Pharmaceutical Fraud Settlements: Off-Label Marketing Continues?
Reporter Susan Todd wrote a fine article in the June 6, 2010 Star –Ledger about off-label marketing. “There are very few companies that haven’t had…
Read More »Johnson & Johnson Subsidiaries to Pay More Than $81 Million to Resolve Allegations of Off-Label Promotion of Topamax
American pharmaceutical manufacturers Ortho-McNeil Pharmaceutical LLC and Ortho-McNeil-Janssen Pharmaceuticals Inc., both subsidiaries of Johnson & Johnson, have agreed to pay more than $81 million to…
Read More »Alpharma to Pay $42.5 Million to Resolve False Claims Act Allegations
Pharmaceutical manufacturer Alpharma, Inc. has agreed to pay $42.5 million to resolve False Claims Act allegations in connection with the marketing of the morphine-based drug,…
Read More »Guidant Charged in Failure to Report Defibrillator Safety Problems to FDA
Medical device manufacturer Guidant LLC, a wholly-owned subsidiary of Boston Scientific Corporation, was charged Feb. 25, 2010 with criminal violations of the Federal Food, Drug,…
Read More »U.S. Files Suit against Johnson & Johnson for Paying Kickbacks to Nation’s Largest Nursing Home Pharmacy
The United States has filed a civil False Claims Act complaint against drug manufacturer Johnson & Johnson (J&J) of New Brunswick, N.J., and two of…
Read More »Texas Hospital Group Pays $27.5 Million for False Claims Act Allegations
South Texas Health System, a McAllen, Texas-based hospital group, has agreed to pay the United States $27.5 million to settle claims that it violated the…
Read More »Four Pharmaceutical Companies Pay $124 Million for False Claims Act Violations
Mylan Pharmaceuticals, UDL Laboratories, AstraZeneca Pharmaceuticals and Ortho McNeil Pharmaceutical have entered into settlement agreements for a total of $124 million to resolve claims that…
Read More »Pfizer to Pay $2.3 Billion in Largest Healthcare Fraud Settlement in Government’s History
Pfizer Inc. and its subsidiary Pharmacia & Upjohn Company Inc. have agreed to pay $2.3 billion to resolve criminal and civil liability arising from the…
Read More »Quality Control Violation Reports Prompt Drug Maker Mylan to Halt Production, Launch Probe
While Mylan has not publically acknowledged serious problems at its generic drug manufacturing facility, the Pittsburgh Post-Gazette has obtained internal reports alleging that employees at…
Read More »